Log in

NASDAQ:EARSAuris Medical News Headlines

$1.03
+0.05 (+4.83 %)
(As of 08/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.00
Now: $1.03
$1.12
50-Day Range
$0.88
MA: $0.95
$1.17
52-Week Range
$0.65
Now: $1.03
$3.20
Volume492,221 shs
Average Volume192,489 shs
Market Capitalization$4.75 million
P/E RatioN/A
Dividend YieldN/A
Beta0.3

Headlines

Auris Medical (NASDAQ EARS) News Headlines

Source:
DateHeadline
Auris Medical (NASDAQ:EARS) Shares Up 4.8%Auris Medical (NASDAQ:EARS) Shares Up 4.8%
americanbankingnews.com - August 3 at 9:30 PM
Auris Medical (NASDAQ:EARS) Stock Price Passes Below 200-Day Moving Average of $1.06Auris Medical (NASDAQ:EARS) Stock Price Passes Below 200-Day Moving Average of $1.06
www.americanbankingnews.com - July 31 at 5:38 AM
Auris Medical Announces Completion of Enrollment into First Part of TRAVERS Phase 2 Study with AM-125 in VertigoAuris Medical Announces Completion of Enrollment into First Part of TRAVERS Phase 2 Study with AM-125 in Vertigo
finance.yahoo.com - July 29 at 12:51 PM
Auris Medical (NASDAQ:EARS) Trading Down 5.6%Auris Medical (NASDAQ:EARS) Trading Down 5.6%
www.americanbankingnews.com - July 23 at 1:59 PM
As COVID-19 spreads, potentially deadly fungus infects L.A. County healthcare facilityAs COVID-19 spreads, potentially deadly fungus infects L.A. County healthcare facility
www.latimes.com - July 20 at 1:55 PM
Auris Medical Announces Pricing of $5.5 Million Registered Direct OfferingAuris Medical Announces Pricing of $5.5 Million Registered Direct Offering
www.bloomberg.com - June 17 at 2:41 PM
Auris Medical Announces Positive Top-Line Data from AM-201 Phase 1b Study in Antipsychotic-Induced Weight Gain and Provides Update on TRAVERS Phase 2 StudyAuris Medical Announces Positive Top-Line Data from AM-201 Phase 1b Study in Antipsychotic-Induced Weight Gain and Provides Update on TRAVERS Phase 2 Study
finance.yahoo.com - May 26 at 12:54 PM
Heres Why We Worry About Auris Medical Holdings (NASDAQ:EARS) Cash Burn SituationHere's Why We Worry About Auris Medical Holding's (NASDAQ:EARS) Cash Burn Situation
finance.yahoo.com - May 10 at 4:14 PM
Here's Why We Worry About Auris Medical Holding's (NASDAQ:EARS) Cash Burn SituationHere's Why We Worry About Auris Medical Holding's (NASDAQ:EARS) Cash Burn Situation
finance.yahoo.com - May 10 at 4:14 PM
Auris Medical HoldingAuris Medical Holding
www.fool.com - April 30 at 10:13 PM
Auris Medical Provides Business Update and Reports Second Half and Full Year 2019 Financial ResultsAuris Medical Provides Business Update and Reports Second Half and Full Year 2019 Financial Results
finance.yahoo.com - April 16 at 8:13 AM
Auris Medical Provides Update on Intranasal Betahistine Development ProgramAuris Medical Provides Update on Intranasal Betahistine Development Program
finance.yahoo.com - April 3 at 8:36 PM
Menieres Disease Treatment Market 2020 Analysis and Research Report 2026 | Novartis, Pfizer, Auris Medical, Jubilant Cadista, OtonomyMeniere's Disease Treatment Market 2020 Analysis and Research Report 2026 | Novartis, Pfizer, Auris Medical, Jubilant Cadista, Otonomy
www.marketwatch.com - March 31 at 5:17 PM
Auris Medical Holding Ltd. to Host Earnings CallAuris Medical Holding Ltd. to Host Earnings Call
finance.yahoo.com - March 19 at 7:17 AM
Auris Medical advancing intranasal betahistine studiesAuris Medical advancing intranasal betahistine studies
seekingalpha.com - March 5 at 1:11 PM
Auris Medical Provides Update on Ongoing Clinical Trials with Intranasal BetahistineAuris Medical Provides Update on Ongoing Clinical Trials with Intranasal Betahistine
finance.yahoo.com - March 5 at 1:11 PM
Auris Medical Highlights Publication of Study Results Demonstrating Betahistine’s Antiepileptogenic and Anticonvulsant Activity in Murine ModelAuris Medical Highlights Publication of Study Results Demonstrating Betahistine’s Antiepileptogenic and Anticonvulsant Activity in Murine Model
finance.yahoo.com - February 25 at 9:13 AM
Should You Take Comfort From Insider Transactions At Auris Medical Holding Ltd. (NASDAQ:EARS)?Should You Take Comfort From Insider Transactions At Auris Medical Holding Ltd. (NASDAQ:EARS)?
finance.yahoo.com - February 10 at 1:01 PM
BRIEF-Auris Medical Announces Notice Of Allowance For European Patent ApplicationBRIEF-Auris Medical Announces Notice Of Allowance For European Patent Application
www.msn.com - January 10 at 4:41 PM
Auris Medical nabs new patent in Europe; shares up 12% premarketAuris Medical nabs new patent in Europe; shares up 12% premarket
seekingalpha.com - January 10 at 4:41 PM
Auris Medical Announces Notice of Allowance for European Patent ApplicationAuris Medical Announces Notice of Allowance for European Patent Application
finance.yahoo.com - January 10 at 4:41 PM
BRIEF-Auris Medical Announces Formation Of New Subsidiary For Development Projects In Tinnitus And Hearing LossBRIEF-Auris Medical Announces Formation Of New Subsidiary For Development Projects In Tinnitus And Hearing Loss
www.msn.com - December 30 at 5:17 PM
Auris forms new unit focused on tinnitus and hearing lossAuris forms new unit focused on tinnitus and hearing loss
seekingalpha.com - December 30 at 5:17 PM
Auris Medical Holding Ltd. Common Shares (Bermuda) (EARS) Earnings Report DateAuris Medical Holding Ltd. Common Shares (Bermuda) (EARS) Earnings Report Date
www.nasdaq.com - November 21 at 12:47 AM
Meniere’s Disease Drugs Market 2019 Global Research and Clinical Analysis – Roche, Novartis, Pfizer, Auris MedicalMeniere’s Disease Drugs Market 2019 Global Research and Clinical Analysis – Roche, Novartis, Pfizer, Auris Medical
www.marketwatch.com - November 13 at 9:44 AM
Do Institutions Own Auris Medical Holding Ltd. (NASDAQ:EARS) Shares?Do Institutions Own Auris Medical Holding Ltd. (NASDAQ:EARS) Shares?
finance.yahoo.com - November 11 at 2:44 PM
Auris Medical up 2% premarket on AM-201 dataAuris Medical up 2% premarket on AM-201 data
seekingalpha.com - October 11 at 12:30 PM
Auris Medical Announces Positive Interim Results from AM-201 Phase 1b Study in Antipsychotic-Induced Weight GainAuris Medical Announces Positive Interim Results from AM-201 Phase 1b Study in Antipsychotic-Induced Weight Gain
finance.yahoo.com - October 11 at 12:30 PM
Auris clarifies endpoint for Phase 2/3 study of Keyzilen for tinnitus; shares up 3%Auris clarifies endpoint for Phase 2/3 study of Keyzilen for tinnitus; shares up 3%
seekingalpha.com - September 13 at 10:24 AM
Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development ProgramAuris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program
finance.yahoo.com - September 13 at 10:24 AM
Auris Medical nabs new patent in U.S. and EuropeAuris Medical nabs new patent in U.S. and Europe
seekingalpha.com - September 11 at 11:39 AM
Auris Medical Announces Notices of Allowance for U.S. and European Patent Applications Covering Intranasal BetahistineAuris Medical Announces Notices of Allowance for U.S. and European Patent Applications Covering Intranasal Betahistine
finance.yahoo.com - September 11 at 11:39 AM
Auris Medical Announces Appointment of New Chief Financial OfficerAuris Medical Announces Appointment of New Chief Financial Officer
finance.yahoo.com - September 4 at 9:41 AM
Auris Medical Announces Formation of Scientific Advisory Board for Tinnitus ProgramsAuris Medical Announces Formation of Scientific Advisory Board for Tinnitus Programs
finance.yahoo.com - August 26 at 7:53 PM
Auris Medical Holding Ltd. (EARS) CEO Thomas Meyer on Q2 2019 Results - Earnings Call TranscriptAuris Medical Holding Ltd. (EARS) CEO Thomas Meyer on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 15 at 8:02 PM
Auris Medical Provides Business Update and Reports First Half 2019 Financial ResultsAuris Medical Provides Business Update and Reports First Half 2019 Financial Results
finance.yahoo.com - August 15 at 9:05 AM
Auris Medical Announces Randomization of First Patient in AM-125 Phase 2 Trial in Acute VertigoAuris Medical Announces Randomization of First Patient in AM-125 Phase 2 Trial in Acute Vertigo
finance.yahoo.com - July 30 at 8:35 AM
Auris Medical Completes Enrollment of Phase 1b Proof-Of-Concept Trial of AM-201 in Antipsychotic-Induced Weight GainAuris Medical Completes Enrollment of Phase 1b Proof-Of-Concept Trial of AM-201 in Antipsychotic-Induced Weight Gain
finance.yahoo.com - July 3 at 7:01 PM
Savara Plunges on Failure of Late-Stage Study on MolgradexSavara Plunges on Failure of Late-Stage Study on Molgradex
finance.yahoo.com - June 13 at 12:47 PM
Auris updates on key upcoming milestonesAuris updates on key upcoming milestones
seekingalpha.com - May 23 at 7:32 PM
Auris Medical Holding Ltd Provides Corporate UpdateAuris Medical Holding Ltd Provides Corporate Update
finance.yahoo.com - May 23 at 7:32 PM
Auris Medical Holding Ltd Regains Compliance with Nasdaq Minimum Bid Price RuleAuris Medical Holding Ltd Regains Compliance with Nasdaq Minimum Bid Price Rule
finance.yahoo.com - May 21 at 5:51 AM
Auris Medical Announces Closing of Two US Patent Acquisitions Related to the Use of Betahistine for the Treatment of Depression and ADHDAuris Medical Announces Closing of Two US Patent Acquisitions Related to the Use of Betahistine for the Treatment of Depression and ADHD
finance.yahoo.com - May 15 at 9:55 PM
Auris Medical Announces Closing of Public Offering of Common SharesAuris Medical Announces Closing of Public Offering of Common Shares
finance.yahoo.com - May 15 at 9:55 PM
Auris Medical down 15% on equity offeringAuris Medical down 15% on equity offering
seekingalpha.com - May 13 at 8:02 PM
Auris Medical Holding Ltd.:Auris Medical Holding Ltd.:
finance.yahoo.com - May 13 at 8:02 PM
Auris Medical Reaches Midpoint for Enrollment in AM-201 Phase 1b Proof-of-Concept Study in Antipsychotic-Induced Weight GainAuris Medical Reaches Midpoint for Enrollment in AM-201 Phase 1b Proof-of-Concept Study in Antipsychotic-Induced Weight Gain
finance.yahoo.com - May 7 at 7:08 PM
Auris Medical Holding Ltd.Auris Medical Holding Ltd.
www.barrons.com - May 1 at 7:35 PM
Auris Medical Announces Reverse Stock SplitAuris Medical Announces Reverse Stock Split
www.nasdaq.com - April 30 at 7:00 PM
Auris Medical Provides Update on Tinnitus Drug Development StrategyAuris Medical Provides Update on Tinnitus Drug Development Strategy
finance.yahoo.com - April 25 at 7:23 PM
This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.